NFKB1 and systemic lupus erythematosus: In particular, we analyzed the activation status of proteins involved in signaling pathways classically targeted by E2 and described as dysregulated in SLE T cells (i.e., the mitogen-activated protein kinases ERK and JNK, Akt, and NF-kB) [19–21].